Sport and Self Esteem in Patients Living With HIV

Sponsor
Centre Hospitalier le Mans (Other)
Overall Status
Completed
CT.gov ID
NCT03920969
Collaborator
COordination REgionale de lutte contre les IST et le VIH (COREVIH) des Pays de la Loire (Other), Nantes University Hospital (Other), University Hospital, Angers (Other), Hospital, La Roche sur Yon (Other), Hospital, Saint Nazaire (Other), Centre Hospitalier de Cholet (Other)
1,169
1
10.9
106.9

Study Details

Study Description

Brief Summary

Adapted athletic activity has shown benefits in patients with certain chronic diseases, including improving fatigue and pain in patients with cancer, and improving the symptoms of severe depression.

Among Patients Living with Human Immunodeficiency Virus (PLHIV), sport appears to be less common than for people who do not live with HIV. In fact, 44% of PLHIV in a Swiss cohort (10,500 patients) were inactive in 2014, whereas this percentage was 26% in the general population in Switzerland. We did not find any French data on the prevalence of sports activity among PLHIV.

The benefits of sport in PLHIV are numerous: meta-analyzes on interventional studies of aerobic and resistance exercises show a significant improvement in maximum oxygen consumption, muscle strength, percentage of body fat, quality of life and symptoms of depression. An improvement in cognitive function was noted in a randomized study. An Iranian randomized study of 2017 showed an improvement in the CD4 count, after 8 weeks of resistive exercise, but two meta-analyzes of 2016 and 2017 did not find a significant change in CD4 or viral load with physical exercise.

On the other hand, several studies have shown that sports practice improves self-esteem. In addition, an Australian randomized study in 2006 showed an improvement in self-efficacy in PLHIVs after a six-month exercise (aerobic and resistance) program. Furthermore, self-esteem (defined as positive self-esteem) is a factor facilitating adherence to antiretroviral therapy.

The objective of this descriptive study is to evaluate the prevalence of sports activity in a French adult population infected with HIV and to seek an association with self-esteem. In addition, the investigators will look for an association between sport and fatigue, pain, sleep, lymphocyte T CD4 cell levels, viral load.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sports activity

Study Design

Study Type:
Observational
Actual Enrollment :
1169 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of Self-esteem According to the Practice of a Sport Activity in a Population of Adults Living With HIV
Actual Study Start Date :
Feb 1, 2019
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Outcome Measures

Primary Outcome Measures

  1. Assessment of self-esteem according to the sport activity of PLHIV [six months]

    Prevalence of self-esteem (Rosenberg questionnaire) among PLHIV, according to sport activity

Secondary Outcome Measures

  1. Description of the sporting activity of an adult HIV population [Six months]

    Number and frequency of characteristics related to sports activity

  2. Description of factors associated with sports activity: fatigue [Six months]

    Prevalence of fatigue symptoms

  3. Description of factors associated with sports activity: pain [Six months]

    Prevalence of pain symptoms

  4. Description of factors associated with sports activity: sleep [Six months]

    Prevalence of sleep disorders

  5. Search for a correlation between physical activity and HIV activity [6 months]

    Measure of the correlation between the measured physical activity and CD4 levels and HIV load.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patient with HIV

  • aged over 18

  • Patient followed by a physician in one of the participating centers of the Regional coordination of the fight against HIV infection (COREVIH) Pays de la Loire

Exclusion Criteria:
  • Refusal or unability to answer the self-questionnaire.

  • Patient Under guardianship

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Le Mans Le Mans France 72 000

Sponsors and Collaborators

  • Centre Hospitalier le Mans
  • COordination REgionale de lutte contre les IST et le VIH (COREVIH) des Pays de la Loire
  • Nantes University Hospital
  • University Hospital, Angers
  • Hospital, La Roche sur Yon
  • Hospital, Saint Nazaire
  • Centre Hospitalier de Cholet

Investigators

  • Principal Investigator: Lucia Perez, MD, CH Le Mans

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier le Mans
ClinicalTrials.gov Identifier:
NCT03920969
Other Study ID Numbers:
  • CHM-2018-S10/002
First Posted:
Apr 19, 2019
Last Update Posted:
Mar 9, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier le Mans
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2022